Saturday, July 11, 2026

pharma · Stroke · Pancreatic Cancer

Shandong Topscience Biotech

Shandong Suncadia Medicine is a pharma organization headquartered in CN. Primary therapeutic focus areas include Stroke, Pancreatic Cancer, Breast Cancer. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s), an

Rizhao, CN HQ
2005 Founded
15 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Rizhao, CN
Founded
2005
Employees
15
Programs
3
Drugs
4
Patents
0
Clinical program

HRS-7058

Phase 2 · small molecule · Pancreatic Cancer

HRS-7058 for Pancreatic Cancer is a Phase 2 program (small_molecule) at Shandong Suncadia Medicine Co., with 1 ClinicalTrials.gov record(s).

Internal code HRS-7058-205

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Shandong Suncadia Medicine Co.,
Phase
Phase 2
Modality
small_molecule
Indication
Pancreatic Cancer
Status
active
Trials
1

Clinical trials